Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q3 2018 Earnings Conference Call Transcript
Nov 06, 2018 • 05:00 pm ET
Good day, ladies and gentlemen, and welcome to the Q3 2018 Aclaris Therapeutics Incorporated Earnings Conference Call. (Operator Instructions) As a reminder, today's conference is being recorded. I would now like to turn the call over to Kamil Ali-Jackson, Chief Legal Officer. You may begin.
Thank you. I'm Kamil Ali-Jackson, Chief Legal Officer for Aclaris. Please note that earlier today Aclaris issued its press release announcing third quarter 2018 financial results. For those of you who've not yet seen it, you will find the release posted in the Investor section of our website at www.aclaristx.com. Joining me for the call today are Dr. Neal Walker, President and CEO; Dr. Stuart Shanler, our Chief Scientific Officer; Frank Ruffo, our CFO; Brett Fair, our Chief Commercial Officer; and David Gordon, our Chief Medical Officer. (Forward-Looking Cautionary Statements) Please be advised that today's call is being recorded and webcast. A link to the webcast is posted in the Investors section of our website. I'll now turn the call over to Dr. Neal Walker, President and CEO of Aclaris. Neal?